Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 202† | — | 138† | 122† | 110† |
| Net profit | 32 | 31 | 18 | 16 | 11† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Bhavin Mukund Mehta | Executive Director | June 30, 2026 |
| Mira Bhavin Mehta | Executive Director | June 30, 2026 |
| Mukund Prataprai Mehta | Executive Director | June 30, 2026 |
| Dipen Jayantilal Jain | Independent Director | June 30, 2026 |
| Vasudev Krishna Murti | Independent Director | June 30, 2026 |
| Venkita Subramanian Rajan | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
